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function came with the mouse mutant shiverer, a natu-Frank Zimmermann, Ian R. Griffiths,*
rally occurring MBP null allele (Roach et al., 1985). Shiv-and Klaus-Armin Nave
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dense line (MDL), the ultrastructural correlate of intracel-University of Heidelberg
lular myelin compaction. Although the overall lack ofD-69120 Heidelberg
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shiverer mice have established that MBP is required for*Department of Veterinary Clinical Studies
intracellular membrane adhesion (Readhead et al., 1987;University of Glasgow
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more complex pathogenic mechanisms.
PLP isan integral “four-helix-span”membrane proteinSummary
with a molecular mass of 30 kDa (Milner et al., 1985;
Popot et al., 1991; Weimbs and Stoffel, 1992). A smallerTwo proteolipidproteins, PLP and DM20, are the major
isoform, termed DM20 (molecular mass 26.5 kDa), ismembrane components of central nervous system
derived by alternative mRNA splicing (Nave et al., 1987).(CNS) myelin. Mutations of the X-linked PLP/DM20
DM20 is detectable early in the oligodendrocyte lineagegene cause dysmyelination in mouse and man and
preceding many other myelin proteins (Ikenaka et al.,result in significant mortality. Here we show that mu-
1992; Timsit et al., 1995; Dickinson et al., 1996), but itstant mice that lack expression of a targeted PLP gene
function at these early stages is not known. The primaryfail to exhibit the known dysmyelinated phenotype.
structure of PLP/DM20 is highly conserved (100% be-Unable to encode PLP/DM20 or PLP-related polypep-
tween mouse and man), which suggests that the proteintides, oligodendrocytes are still competent to my-
engages in multiple protein–protein interactions. Moreelinate CNS axons of all calibers and to assemble com-
recently, DM20 has been identified as the prototype ofpacted myelin sheaths. Ultrastructurally, however, the
a new protein family, which also includes two neuronalelectron-dense ‘intraperiod’ lines in myelin remain
proteins, M6A (EMA) and M6B (Baumrind et al., 1992;condensed, correlating with its reduced physical sta-
Lagenaur et al., 1992; Yan et al., 1993).bility. This suggests that after myelin compaction, PLP
The view that PLP/DM20 and MBP play similar roles
forms a stabilizing membrane junction, similar to a
in myelin received initial strong support when naturally
“zipper.” Dysmyelination and oligodendrocyte death
occurring PLP mutants were identified (Nave et al., 1986;emerge as an epiphenomenon of other PLP mutations
Hudson et al., 1987). Point mutations and RNA spliceand have been uncoupled in the PLP null allele from
defects were documented in the jimpy and the jimpy msd
the risk of premature myelin breakdown.
mouse, the myelin-deficient rat, and later in other spe-
cies, including a growing number of human patients
Introduction with Pelizaeus-Merzbacher (PMD) disease and X-linked
spastic paraplegia (SPG-2) (reviewed in Hodes et al.,
The formation of myelin sheaths by oligodendrocytes in 1994; Nave and Boespflug-Tanguy, 1996; Seitelberger
the central nervous system (CNS) and Schwann cells in et al., 1996). Point mutations that alter the primary struc-
the periphery provides the cellular basis for rapid im- ture of PLP and DM20 render these proteins as mis-
pulse conduction (Raine, 1984; Bunge and Fernandez- folded polypeptides that are unable to exit from intracel-
Valle, 1995). Naturally occuring diseases in which axons lular compartments and are rapidly degraded (Roussel
fail to be ensheathed (“dysmyelination”) or loose their et al., 1987; Gow et al., 1994; Jung et al., 1996).
insulating myelin (“demyelination”) have been described In jimpy mice, immature oligodendrocytes are in-
in mouse and man and comprise a heterogenous group creased, and the majority of differentiated oligodendro-
of disorders associated with a characteristic impairment cytes die at an early stage with morphological features
of motor and sensory functions (for review see Lupski of apoptosis (Knapp et al., 1986; Skoff, 1995). Less than
et al. 1993; Snipes et al., 1993; Nave, 1995; Snipes and 5% of the normal number of CNS axons are eventually
Suter, 1995; Nave and Boespflug-Tanguy, 1996). ensheathed, and myelinated axons are ultrastructurally
The elaboration of myelin requires the large-scale syn- abnormal (Duncan et al., 1989). PLP-mutant mice show
thesis of myelin-specific lipids and membrane-associ- significant deficits of normal motor performance and, in
ated proteins (Pfeiffer et al., 1993; Campagnoni, 1995), most cases, tremors, seizures, and premature death.
presumed toplay specific roles in spiral wrapping,mem- Some of the natural rodent mutants exert no obvious
brane compaction, and the fine architecture of the multi- effect on oligodendrocyte survival but display a wide-
layered myelin sheath. Two membrane-associated pro- spread dysmyelination of the CNS (Schneider et al.,
teins predominate in abundance, myelin basic protein 1992; Tosic et al., 1994). The rumpshaker mutation in
(MBP) and proteolipid protein (PLP/DM20) (Braun, 1984; mice has demonstrated that this dysmyelination is not
Lees and Brostoff, 1984). It is widely believed that the the cause of oligodendrocyte death (Schneider et al.,
1992).two proteins play similar structural roles in myelin and
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A further complication in understanding the PLP- tions of two clones yielded highly chimeric mice, which
were used to establish independent transgenic lines thatlinked dysmyelinating diseases was the observation that
did not differ in phenotype. Heterozygous femalesincreasing the wild-type PLP gene dosage results, by
(plp2/1) were bred with wild-type (plp1/Y) males toitself, in a phenotype that is in many respects similar to
obtain hemizygous mutants (plp2/Y). In some crosses,the effect of a mutation. Only 2-fold transcriptional PLP/
we used males from PLP-transgenic lines (#66 and 72)DM20 overexpression in transgenic mice is sufficient to
transmitting an autosomal copy of the wild-type PLPturn the PLP gene into a disease gene (Readhead et al.,
gene (Readhead et al., 1994). In the progeny of the latter1994), and slightly higher overexpression rates cause
cross, we expected 50% hemizygous mutants, aboutabnormal oligodendrocyte death (Kagawa et al., 1994).
half of which should be immediately “rescued” byDuplications of the human PLP gene have likewise been
transgenic complementation. All genotypes were foundassociated with PMD (Ellis and Malcolm, 1994; Carango
at the expected frequencies, and mice developed nor-et al., 1995; Inoue et al., 1996) and account for about 50%
mally.of all familial cases of this disease (Nave and Boespflug-
Tanguy, 1996).
Taken together, the available genetic data have sug- Motor Performance
gested that normal myelin formation is extremely sensi- In contrast to most naturally occurring PLP mutants,
tive to qualitative and quantitative alterations in the ex- hemizygous males were fully viable, reproduced nor-
pression of the PLP/DM20 gene. In all known mutations, mally, and thus allowed the generation of homozygous
the cellular phenotypes are complex because different females (plp2/2). Obvious signs of abnormal motor de-
pathological events overlap. These are (1) the intracellu- velopment were lacking, and tremors or seizures were
lar retention of misfolded PLP, (2) the dysmyelination of absent. We performed a more specialized locomotor
CNS axons, most notably the numerous ‘naked’ axons test of plp2/Y mice at the age of 6 months. This cohort
in white matter tracts, (3) abnormal myelin compaction, of mice was tested again at 12 months of age to detect
and (4) in many mutants, the premature death of oligo- possible losses of motor performance. The ‘rotarod test’
dendrocytes with morphological features of apoptosis. (Figure 2) failed to reveal any performance deficit, sug-
We have constructed two independent lines of gesting that motor development is not compromised in
transgenic mice that represent null alleles and com- the absence of PLP and DM20. The same paradigm
pletely lack expression of PLP, DM20, or PLP/DM20- has revealed significant motor deficits associated with
dysmyelination of plpneo mice (Boison et al., 1995). Werelated polypeptides. Surprisingly, none of the major
could likewise show a significant motor defect of PLP-pathological features previously associated with the
transgenic rumpshaker mice, which served as positivemutations of this gene were found. Oligodendrocytes
controls for this assay (the wild-type PLP-transgene im-survive, are myelination competent, and recognize small
proves the rumpshaker phenotype but does not com-and large-caliber axons. However, compacted myelin
pletely rescue it; A. Schneider, I. Griffiths, and K.-A.sheaths areextremely susceptible to loosen and decom-
Nave, unpublished data). There was also no behavioralpact in conditions of suboptimal fixation during tissue
abnormality of plp2/Y mice when challenged to balanceprocessing. There is no equivalent evidence of in vivo
on a thin horizontal bar and when tested in a standardmyelin breakdown nor functional consequences on be-
open field setting (data not shown).havior, at least in the first year of life. At older ages,
a destabilization of compacted myelin becomes more
prominent and may indicate a slowly progressive myelin Loss of PLP/DM20 Gene Expression
pathology. We have also generated double-mutant mice By in situ hybridization, using a riboprobe complemen-
that lack both PLP and MBP, and which confirm that tary to exons 1–7, no PLP signal was detected in plp2/Y
the two major myelin proteins serve very different func- brain sections, in contrast to a strong hybridization in
the wild type (data not shown). By Northern blot analysistions in the assembly of CNS myelin.
of adult plp2/Y brain RNA, no PLP mRNA was detect-
able (Figure 1C) except for a 3.4 kb mRNA of very low
abundance (see Discussion). The corresponding cDNAResults
was cloned by reverse transcription–polymerase chain
reaction (PCR) (using primers from PLP exons 1 andGene Targeting and Transgenic Complementation
3), and its nucleotide sequence was determined. ThisTo create a true PLP/DM20 null allele, we constructed
analysis revealed that intron 1 of the mutant PLP tran-a gene replacement vector that eliminates, by homolo-
script was removed due to a cryptic donor splice sitegous recombination, the translation start site for PLP
located in the neo gene. The 3.4 kb RNA contains noand DM20.The 39 part of exon 1, including the translation
open reading frame for PLP or PLP-related peptides.start codon (Ikenaka et al., 1988), and a 2.5 kb fragment
The absence of PLP and DM20 in plp2/Y mice was con-of the first intron were replaced by the neomycin (neo)
firmed by Western blot analysis of purified myelin prepara-resistance gene as shown schematically in Figure 1A.
tion (Figure 1D) or total brain extracts (not shown).Electroporation of mouse embryonic stem cells resulted
in the generation of G418-resistant clones with a 1-in-46
frequency of correct targeting events (six clones). Ho- Immunocytochemistry of Myelin
mologous recombination was confirmed by Southern In white matter tracts of hemizygous males (and homo-
blot analysis (Figure 1B). A neo probe was used to verify zygous plp2/2 females), no myelinated fibers were im-
munostained with an antibody against PLP/DM20,a single integration event (not shown). Blastocyst injec-
Figure 1. Targeted Inactivation of the Myelin Proteolipid Protein Gene
(A) Structure of the mouse PLP/DM20 gene (wild type), the targeting construct, and the targeted gene. The PLP/DM20 locus comprises seven
exons indicated as open boxes. Note that after homologous recombination, 2.5 kb of intron 1 and the 39 end of exon 1 are removed, which
also deletes the translational initiation codon (ATG) located adjacent to the first exon–intron boundary (enlarged on top). The neomycin
resistance gene (neo) is transcribed in antisense orientation relative to PLP. Positions of the 59 probe, used for Southern analysis, and primers
#1 (sB4ext), #2 (PLP59a), and #3 (Mkneo1), used for genotyping, are indicated. Restriction sites are B (BamHI), K (KpnI), S (SphI), and X (XhoI).
(B) Southern analysis of genomic DNA from wild-type (1/Y), heterozygous (1/2), and hemizygous (2/Y) mutant mice. Correct genomic targeting
introduces an additional SphI restriction site (in neo). When hybridized to the 59 probe, SphI fragments are 17.7 kb in the wild-type and 5.8
kb in the mutant allele. When stripped and rehybridized to a neo-specific probe, a single band is obtained with DNA from heterozygous (1/2)
and hemizygous (2/Y) mice but not with DNA from wild-type mice (not shown).
(C) Northern analysis of adult brain RNA (5 mg/lane). Transcription of the wild-type PLP/DM20 gene yields differentially polyadenylated mRNAs
of 3.2 kb, 2.4 kb, and 1.6 kb (1/Y), also detectable in brains of heterozygous females (2/1). Gene targeting drastically reduces the steady-
state level of PLP transcripts, most likely due to “antisense” transcription of neo in close proximity to the PLP promoter. A 3.4 kb RNA that
lacks any PLP/DM20 coding capacity is visible on long exposures (see text).
(D) Western blot analysis. Purified CNS myelin from wild-type, heterozygous (1/2), and hemizygous (2/Y) mice (10 mg/lane) stained with a
polyclonal antiserum directed against the common C-terminus of PLP and DM20. Both proteolipids are also absent when total brain extracts
are analyzed (not shown).
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optic nerve sections in adult heterozygotes with an anti-
PLP/DM20 antibody revealed a mosaicism that varied
from patches containing predominantly PLP-positive
or -negative sheaths to regions of complete intermin-
gling (Figures 3E and 3G). There was no astrocytosis
associated with the patches of PLP-negative fibers (Fig-
ure 3F). The absence or presence of PLP/DM20 affected
large and small diameter fibers (Figure 3G), and myelin
sheaths of PLP-negative fibers were of equal thickness
and well compacted when adjacent sections were
stained for MBP.
Oligodendrocyte Survival
We noticed that in male F0 chimeras that were 90%–
100% embryonic stem (ES) cell–derived (as estimated
by the agouty coat color marker), only 30% of the myelin
sheaths in the spinal cord were PLP-negative and thus
assembled by mutant oligodendrocytes (data not shown).
This suggested that PLP/DM20-negative cells could
have a developmental defect. However, counts of PLP/
DM20 immunoreactive sheaths in sections of the tho-
racic cord of F1 heterozygote females (n 5 4) revealed a
proportion of 57% 6 3% PLP-positive sheaths (mean 6
SEM; n 5 400). This number is close to the theoretical
value of 50% (Tan et al., 1995) and demonstrates, at
least indirectly, that PLP/DM20-deficient oligodendro-
cytes survive and ensheath normally in the “competi-
tive” situation of the chimeric CNS. No evidence of in-
creased cell death or degenerative changes were seen
in PLP/DM20-deficient oligodendrocytes (not shown).
Myelin Defects at the Ultrastructural Level
Multiple regions of the CNS from plp2/Ymice, examined
in 1 mm resin sections at various ages from 5 weeks to 1
year, appeared normally myelinated. This was confirmed
on ultrathin sections from spinal cord of adult mice (Fig-
Figure 2. Motor Performance of plpnull Mice
ure 4A). No difference was noted in the proportion of
(A) The ‘rotarod’ test was used to measure motor performance of myelinated axons, myelin sheath thickness, or size
6-month-old plpnull mice (closed bars) and age-matched controls
range of myelinated fibers between plp2/Y and wild-(open bars). In a series of five consecutive trials, the cumulative
type mice. This is in complete contrast to the dysmyeli-time (in seconds 6 SEM) was scored in which animals of each
genotype (n 5 6) were able to stay on a slowly rotating roller. After nation seen in even the least severe of the natural plp
15 s at rest, rotating speed (starting at 1 rpm) was increased in 60 s mutants, rumpshaker (Figure 4B). In regions with excel-
intervals to 2, 4, 8, 12, 16, and 20 rpm. There was no detectable lent fixation (assessed by criteria such as size of extra-
motor defect in the absence of PLP expression. cellular space, swelling of astrocyte processes, and
(B) The rotarod assay was repeated at 1 year of age, using the
swelling of mitochondria), myelin of null mutants wassame cohort of mice. Whereas the overall performance was slightly
compacted. However, the difference between MDL anddecreased, the null allele was not significantly impaired.
(C) To show that the paradigm is principally adequate to reveal a intraperiod line (IPL) was less distinct than in wild type
mild dysmyelination, a cohort of PLP-transgenic rumpshaker mu- (Figures 4C and 4D), with the IPL being a single con-
tants was tested under the same conditions. Note that the total time densed structure, similar in appearance to that seen in
scored in this experiment was reduced compared to that of wild- natural mutants (Figure 4E). In a minority of regions, a
type mice (A and B).
double IPL was noted and could coexist with the con-
densed IPL in the same sheath. Where tissue perfusion
was less than optimal, the sheaths were less compactedwhereas MBP reactivity was strong (Figures 3A and 3B).
No evidence of astrocytosis was present, as assessed and more loose than would be expected in normal mice.
The appearance of the myelin sheath remained un-by GFAP immunostaining (Figure 3C). The periaxonal
localization of myelin-associated glycoprotein (MAG) changed for up to at least 1 year of age, with no evidence
of myelin breakdown and no microglial or macrophagewas unchanged, indicating that this adhesion molecule
has not redistributed and substituted for PLP within response.
We used a serial thick-and-thin sectioning procedurecompacted myelin (Figure 3D). Random X chromosome–
inactivation in females allows a direct side-by-side com- to identify, first by immunocytochemistry of 1 mm resin
sections, individual PLP-positive and -negative fibers inparison of mutant and wild-type myelin processed under
the identical conditions. The staining of spinal cord and the chimeric heterozygous mice, and then the adjacent
PLP/DM20 null Mutation
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Figure 3. Immunocytochemistryof PLP-Defi-
cient White Matter Tracts
(A–C) Immediately adjacent 1 mm resin sec-
tions of dorsal columns of cervical spinal cord
from a 4-month-old plp2/Y mouse immuno-
stained by the PAP technique for PLP (A),
MBP (B), and GFAP (C). The myelin sheaths
show strong staining with MBP but are nega-
tive for PLP. The distribution of GFAP-posi-
tive astrocytes is normal, showing a lack of
astrocytosis. Scale bar 5 100 mm.
(D) The cord from the same mouse stained
for MAG, which is distributed normally in the
periaxonal space. Scale bar 5 10 mm.
(E and F) Immediately adjacent sections from
the optic nerve of a plp2/1 heterozygote im-
munostained for PLP (E) and GFAP (F). The
PLP staining shows patches containing pre-
dominantly PLP1 or PLP2 myelin sheaths.
There is no astrocytosis associated with the
PLP2 areas. Scale bar 5 100 mm.
(G) Region of spinal cord lateral column from
a plp2/1 heteozygote immunostained for
PLP. A mosaic of staining is present with no
selectivity of fiber size on the basis of pres-
ence or absence of PLP staining. Scale bar 5
5 mm.
thin sections to determine their specific ultrastructural purified myelin from adult plp2/Y and control mice. The
features by electron microscopy. The findings in PLP- overall pattern of size-separated proteins, stained with
negative fibers of the chimera were identical to those Coommassie blue (Figure 5A) or by silver impregnation
in plp2/Y mice, with well compacted regions of a sheath (not shown), did not differ beween wild-type and mutant
together with areas of looser appearance; the IPL was mice, except for the obvious lack of PLP in plp2/Y
frequently condensed (Figures 4F–4H). brains. No protein emerged at the abundance that would
be sufficient to compensate for the lack of the two pro-
teolipids. By Western blot analyses (Figure 5B), otherCompensatory Mechanisms
known CNS myelin proteins (MBP, MAL, and OSP) wereTo investigate the possibility that other myelin proteins
compensate for the lack of PLP/DM20, we analyzed unchanged, and PNS myelin proteins tested (P0 and
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Figure 4. Ultrastructure of CNS Myelin in PLP
Mutant Alleles
(A) Electron micrograph of spinal cord from
adult plpnull/Y mice shows axons surrounded
by compacted myelin sheaths of appropriate
thickness. Axons of large and small diameter
are myelinated. Scale bar 5 2 mm.
(B) In comparison with the well-myelinated
tissue shown in (A), the spinal cord of an adult
rumpshaker mouse (plprsh/Y) is severely dys-
myelinated. Many axons are naked or thinly
myelinated. Note that plprsh represents the
least severe phenotype of the spontaneous
plp mutant mice. Scale bar 5 2 mm.
(C–E) Myelin sheaths from wild-type (C),
plp2/Y (D), and plpjp mice (E) show differ-
ences in periodicity of myelin. Note that the
IPL is condensed in plpnull mice, resembling
the MDL. Scale bar 5 50 nm.
(F–H) Spinal cord from a chimeric female
(plp1/2). A section immediately adjacent to
the ultrathin section was immunostained for
PLP (not shown), allowing the identification
of two PLP-positive (p) fibers and one PLP-
negative fiber (n). Myelin sheaths of a PLP-
positive (G) and a PLP-negative (H) fiber are
shown. The arrows (H) indicate regions where
the distiction between the IPL and MDL is
lost. Same scale as in (C).
PMP22) were not induced in oligodendrocytes (data not than about 2 months, predominantly in small diameter
axons, throughout the CNS (not shown). The signifi-shown). We also immunostained blots for the two DM20
homologs, M6A and M6B. Both proteins were detected cance of axonal swellings, which have been reported in
several of the natural PLP mutants, is uncertain andby Western blot analysis of purified myelin, however, at
a low abundance. M6A (but not M6B) was about 2-fold under investigation at present.
more abundant in mutant mice relative to controls. This
was unexpected because M6A expression previously MBP*PLP Double-Mutant Mice
Neither a mutation of the PLP gene nor of the MBP genehas not been associated with oligodendrocytes (Lagen-
aur et al., 1992). Our results were confirmed with inde- blocks the assembly of CNS myelin completely. Can the
spiral wrapping of membranes proceed in the absencependent myelin preparations, but the low overall abun-
dance of M6A relative to PLP/DM20 suggests that this of both proteins? We have crossed the plpnull allele with
shiverer (shi) mice to generate double-mutant mice lack-increase is not a sufficient compensatory mechanism.
It also cannot be formally excluded that M6A immunore- ing both proteins. Although shi/shi and shi/shi*plp2/Y
mice exhibited a very similar phenotype with ataxia andactivity derives from contaminating axonal membranes.
All of these observations in the adult brain cannot rule tremors, it was striking that all double mutants were long-
lived (.6 months), whereas shi/shi mice died prematurelyout the existence of compensatory mechanisms at ear-
lier stages of oligodendrocyte development. at about 3 months of age. The morphological basis for this
finding awaits to be identified, as the overall appearance
of double-mutant mice (Figure 6A) was very similar orOther Changes
In general, the CNS and PNS of plp2/Y mice were indis- identical to that of the natural shi/shi phenotype. Many
axons were naked, and any sheaths present were thin.tinguishable from wild type at all ages studied (up to 1
year). Although the majority of axons were normal, we Also in common with shiverer, the myelin of double mu-
tants was frequently decompacted, lacking an MDL.noted some axonal spheroids, particularly in mice older
PLP/DM20 null Mutation
65
Figure 5. Myelin Proteins in plpnull Mice
(A) Coomassie Blue staining of total protein (5 mg/lane) from purified myelin demonstrates the absence of PLP and DM20 in plpnull (2/Y)
mutants in comparison to wild-type controls (1/Y). There is no compensatory upregulation of other myelin proteins. PLP has a relative mobility
of 24 kDa as shown (Lees and Brostoff, 1984), and DM20 (relative mobility: 20 kDa) is not stained as efficiently. MBP isoforms are prominent.
(B) Western blot analysis of known membrane proteins (indicated on the left) in purified myelin of adult plpnull mutants (2/Y) and wild-type
controls (1/Y) (10 mg/lane). Peripheral myelin proteins are absent (not shown). Note that the neuronal M6A protein is detected at about a
2-fold higher level but at a very low overall abundance.
However, the IPL was identifiable and often of increased in these mice, a complete disintegration of myelin mem-
branes would be expected.density, similar to that of the plp2/Y mice (Figure 6B).
However, the specific ultrastructural defects of myelin
in PLP-deficient mice processed for electron micros-Discussion
copy are informative and suggest a function of proteo-
lipids in the myelin architecture. The extracellular com-The normal function of PLP/DM20 has remained ob-
paction of adjacent membranes appears abnormallyscure because mutations of its gene are associated with
condensed (so that in most regions of a sheath, thean unusually wide spectrum of pathological abnormali-
MDL and IPL are difficult to distinguish). This featureties (Nave and Boespflug-Tanguy, 1996). It has been
resembles other “PLP-deficient” mutants (Duncan et al.,speculated that the pleiotropic defects reported for
1987; 1989; Schneider et al., 1995), is in line with X-rayjimpy or rumpshaker mice and other rodent mutants
diffraction data (Kirschner et al., 1984),and can be corre-(modeling Pelizaeus-Merzbacher disease and SPG-2 in
lated with a markedly reduced stability of the myelinhumans) result from the complicated interaction of a
sheath. PLP-deficient myelin, although compacted inloss-of-function and a gain-of-function effect, but the
vivo, is extrasensitive to the osmoticstress during perfu-relative contribution of each is unknown.We have exper-
sion–fixation, yielding more “fixation artifacts” than nor-
imentally uncoupled the two disease processes by com-
mal myelin. Such a difference in physical stability has
pletely eliminating expression of a targeted PLP gene
been convincingly documented in the CNS of chimeric
in mice and have compared this new mutation with pre-
females in which PLP-positive and -negative myelin
viously identified alleles. Clearly, mice that have no cod- sheaths could be processed under identical conditions.
ing capacity for PLP or PLP-related polypeptides differ Our findings challenge the previously held view that
at the molecular, cellular, and behavioral level. PLP is required to assemble compacted myelin, a model
that was self-suggestive given the abundance of this
The Function of PLP/DM20 in Myelin protein. For comparison, such a critical function was
Most important, with respect to PLP function, is the expected for MBP and for P0 (in peripheral myelin) and
observation that all mutant oligodendrocytes differenti- has been confirmed with the corresponding mutants
ate completely and spirally enwrap myelination-compe- (Readhead et al., 1987; Giese et al., 1992). We propose
tent axons, irrespective of their size. At the electron that PLP/DM20 is not primarily responsible for mem-
microscopic level, intra- and extracellular membrane ap- brane compaction, serving a different cellular function
positions are clearly visible. Over a period of 1 year, than P0. Likewise, there is no in vitro evidence that PLP
compacted myelin displays no direct or indirect signs has the same adhesive properties as P0 (Filbin et al.,
of premature breakdown invivo. Moreover, inMBP*PLP- 1990). However, proteolipids may well engage in homo-
deficient double-mutant mice, the IPL but not the MDL philic interactions, forming “struts” that expand the
width of the IPL and bridge the extracelluar gap (seeis preserved. If any loosening of the IPL were genuine
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plpneo and dm20neo mice is much less severe (Boison and
Stoffel, 1994). It has been pointed out that “antisense”
transcriptionof theneo gene, starting about 10 kb down-
stream of the PLP transcription start site, lowers the
steady state level of PLP mRNA (Figure 3 of Boison et
al., 1995). Genetically, plpneo mice are therefore more
complex than the natural PLP mutants because abnor-
mal RNA splicing and reduced gene expression overlap.
Truncated polypeptides were not detected in purified
myelin (Boison and Stoffel, 1994) presumably because
they are abnormally folded, retained in the endoplasmic
reticulum (ER), and rapidly degraded (Roussel et al.,
1987; Hammond and Helenius, 1994; Gow et al., 1994).
A comparable RNA splice defect has been carefully
studied in the jimpy mouse, in which truncated proteolip-
ids are extremely difficult to detect (Yanagisawa and
Quarles, 1986; Benjamins et al., 1994; Fannon et al.,
1994). Plpneo and dm20neo mice synthesize myelin mem-
branes but fail to compact them. This allows MAG immu-
noreactivity to spread widely (Figure 4 of Boison et al.,
1995), compared to the periaxonal localization of MAG
in the wild-type (Martini and Schachner, 1986) and in
the null allele (this study). Interestingly, a reinvestigation
of the mutant strain suggested that myelin disruption
was partly artifactual (Rosenbluth et al., 1996). Regard-
less of the true myelin morphology, oligodendrocytes in
plpneo mice failed to myelinate the majority of small-
caliber axons in the optic nerve (Figure 7 of Boison
et al., 1995) and spinal cord. Dysmyelination causedFigure 6. Myelin Ultrastructure of PLP*MBP Double-Mutant Mice
significant motor defects, as documented with the ro-Spinal cord from an mbp2/2*plp2/y mouse shows marked dysmy-
elination, similar to that seen in shiverer mice. Axons have either no tarod test (Figure 6 of Boison et al., 1995), and nerve
myelin sheaths or thin, poorly compacted sheaths. Ultrastructure of conduction velocities were reduced (Gutierrez et al.,
the sheath shows splitting and nonfusion at the MDL (open arrows), 1995).
typical of the homozygous shiverer. Note that the IPL is formed in
the absence of PLP/DM20 as a single fused line and appears as a
denser structure (closed arrows). Scale bars: A 5 2 mm, and B 5 PLP-Related Polypeptides
50 nm. and CNS Dysmyelination
A comparison of all of the mutations suggests that even
low amounts of truncated (but PLP-related) polypep-also Kitagawa et al., 1993; Yoshida and Colman, 1996).
tides act as effective inhibitors of myelination. This isSuch specialized interactions may require the prior as-
supported by complementation experiments in whichsociation of the two membranes to engage. We propose
the jimpy mutation had emerged as genetically dominantthat the primary junctions are stabilized by secondary
over an autosomal wild-type PLP transgene (Nadon etPLP/DM20-dependent bonds, a mechanism perhaps
al., 1994; Schneider et al., 1995). Comparing the pheno-modeled best as a “PLP-zipper”, which must be firmly
type of various mutant alleles (as summarized in Tablealigned before it can be closed.
1) with the ability of each to encode a gene product, we
conclude that dysmyelination, as a disorder of myelinComparison of PLP Mutant Mice
synthesis, strictly depends on the expression of PLPPreviously characterized PLP mutations have a wide
or PLP-related polypeptides, and that it constitutes arange of phenotypic expression (Nave and Boespflug-
“continuum” of disease expression. In the order of in-Tanguy, 1996). It is important to compare the results
creasing severity, the pathological changes are (1) thepresented here with a previous report of PLP gene tar-
inability of oligodendrocytes to recognize and myelinategeting (Boison and Stoffel, 1994). In that study, two
small-caliber axons, (2) the premature arrest of myelina-mutants (plpneo and dm20neo) were designed as “isoform-
tion, with abnormally thin sheaths, (3) the failure to rec-specific” knockouts; however, their molecular analysis
ognize and myelinate large-caliber axons, and (4) oligo-revealed an unpredicted and novel defect of RNA splic-
dendrocyte death with features of apoptosis. Theseing: intron 3, containing an inserted neo gene, is not
findings correlate with an increasing “clinical” severityspliced out (Figure 1 of Boison et al., 1995). Because
from locomotordefects to tremors, seizures, and prema-the ninth in-frame codon of intron 3 introduces a stop
ture death.into the open reading frame (Ikenaka et al., 1988), the
abnormal splice products of plpneo and dm20neo mice
encode PLP-related proteins of 159 and 124 residues, PLP Toxicity
In jimpy mice, .90% of oligodendrocytes are eliminatedrespectively. Comparable defects of PLP mRNA splicing
are known in mouse and man, but the phenotype of by cell death, coinciding with expression of abnormally
PLP/DM20 null Mutation
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Table 1. Mutations in the PLP Gene and Phenotypes Differ Widely in the Mouse and Have Been Grouped by Increasing Clinical Severity
and the Absence or Presence of Protein Coding Capacity
Dysmyeli-
Polypeptide Abnormal motor nation7 Abnormal
Genotype encoded development of CNS axons oligodendrocyte death Myelin structure8 Reference
plpnull none4 Not detectable Absent No Compacted, This study
condensed IPL,
reduced stability
plpneo 159aa1,4 Mild Small caliber No Uncompacted9 Boison and Stoffel, 1995
plprsh 276aa2,5 Moderate Small and large Compacted Schneider et al., 1992
caliber
plpjp 242aa1,4 Severe (lethal) Most axons Increased Compacted Duncan et al., 1989
plpmsd 276aa3,4 Condensed IPL Skoff, 1995
plp-transgenic 276aa6 Compacted Readhead et al., 1994
The number of predicted amino acids (aa) is indicated and can deviate from full-length PLP (276aa) as a result of abnormal RNA splicing.1
Single amino acid substitutions2,3 are Ile186→Thr and Ala242→Val, respectively. PLP is coexpressed with DM20 (241aa, not indicated), except
in the isoform-specific plpneo and dm20neo alleles. Steady-state RNA levels are either strongly reduced4 (,10% of wild type) or in the normal
range5 (60%). PLP–transgenic mice overexpress6 normal PLP/DM20 mRNA (.150%). Dysmyelination7 is defined as a missing or abnormally
thin axonal ensheathement. Myelin structure8 refers to the ultrastructural features of myelinated axons (IPL, intraperiod line). For plpneo mice9,
different results were reported by Boison et al. (1995) and Rosenbluth et al. (1996). For additional references, see Nave (1995).
spliced PLP mRNA (Skoff, 1995). Combined with our with PMD and revealed a deletion of his PLP gene, com-
prising a human null allele. Retarded motor develop-results and those of Boison et al. (1995), this could be
explained by assuming that jimpy–PLP forms toxic ment, as first signs of a disease, were noticed at about
1 year of age, and hypomyelination was diagnosed by“junk” that perturbs cellular trafficking. However, cloned
jimpy–PLP cDNA has been overexpressed in transiently magnetic resonance imaging several years later. The
patient is now in his 40s and is wheelchair-bound (T.transfected COS7 cells, and the encoded polypeptide,
which is retained in the ER, could be immunostained in Bird, personal communication). A nonsense mutation
found in another patient diagnosed with SPG-2 inter-live cells days after transfection (Jung et al., 1996, and
data not shown). This indicates that the toxicity of mis- rupts the PLP reading frame after a few nucleotides and
must be equivalent to a null allele (O. Boespflug-Tanguy,folded PLP is cell-type specific. Could there be another
link between PLP and oligodendrocyte death? It is personal communication). Thus, complete loss of the
PLP gene function is not tolerated in humans, causingtempting to speculate that prior to myelination, wild-
type PLP (or DM20) associates with other intracellular a mild form of PMD/SPG-2 with late onset and slow
progression. Are there fundamental differences be-proteins that are involved in oligodendrocyte differentia-
tion. When retained in the ER, misfolded (but PLP- tween mouse and human myelin? The biochemical com-
position is nearly identical (Lees and Brostoff, 1984),related) polypeptides may associate with the same pro-
teins altering their function, possibly by being jointly and it is unlikely that PLP, highly conserved in evolution,
serves different functions in different mammalian spe-degraded. The model predicts that the misfolded poly-
peptides in dysmyelinated mutants must have a mini- cies. The incorporation of PLP increases the physical
stability of compacted myelin, but PLP-deficient myelinmum length to maintain a structural homology with wild-
type PLP/DM20. It could explain why an abnormal splice in mice is stable in vivo for at least 1 year, as shown
here, and possibly longer. We suggest that PLP is moreproduct of jimpy mice (encoding 242 residues with three
transmembrane domains) is more “toxic” than the splice relevant for humans because they are long-lived. In hu-
mans, myelin assembly begins around birth and contin-product of plpneo mice (159 residues, two transmem-
brane domains). In all of the other rodent mutants, the ues for several years. We hypothesize that in the ab-
sence of proteolipids, myelin is at a high risk ofsize of PLP (276 residues) is unaltered.
premature breakdown and will degenerate within a few
years and with a similar (absolute) time course lastingMouse Models of Human Diseases
The primary structure of PLP and DM20 is 100% con- several years. Such a disease is expected to show fea-
tures of a developmental disorder in children (PMD/served between mouse and man. PMD (McKusick
312080) has been associated with numerous mutations SPG-2), because it interferes with their normal cognitive
and motor development. In contrast, the plpnull allele ofof the human PLP gene, and some mutations cause
spastic paraplegia (SPG-2, McKusick 312920), a less the mouse has no functional consequences within its
reproductive age but may become manifest as a late-severe and clinically distinct entity.At least one mutation
(Ile186→Thr) is identical in mouse (plprsh) and man (SPG-2) onset neurodegenerative disease in animals .1 year
old. For comparison, the known developmental defects(Schneider et al., 1992; Kobayashi et al., 1994). These
genetic homologies provide an opportunity to investi- of myelination (such as the connatal form of PMD or
dysmyelination in jimpy mice) have a species-specificgate whether expression of the disease phenotype is
also the same. time course: the human disease process is “squeezed”
into the first postnatal weeks of the mouse. We areOur present data suggest that the same mutation can
have different consequences for mouse and man. further investigating preliminary observations that de-
generative myelin changes surface in the plpnull allele ofRaskind et al. (1991) have analyzed a patient diagnosed
Neuron
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of the transgene and reverse primer T7cos (59-GCATAATACGACTCaged mice. It is anticipated that this issue of disease
ACTATAGGGATC-39) at its 39 end, as previously described.progression versus time will be relevant for other mouse
models of human genetic disorders and the understand-
MBP*PLP Double Mutantsing of pathogenic mechanisms.
Double mutant shi/shi*plp2/Y mice were obtained by breeding ho-
mozygous shiverer males (kindly provided by J. Trotter) with homo-
Experimental Procedures zygous plp2/2 females and brother–sister mating of double-hetero-
zygous animals. Presence of the wild-type and mutant MBP alleles
Molecular Cloning was detected with two sets of specific primers (Gomez et al., 1990).
Overlapping clones of the PLP gene were obtained by screening a One primer pair was derived from intronic sequences flanking exon
mouse Sv129 genomic library (Stratagene) with probes correspond- 6 of the normal MBP gene (forward: 59-AGCTCTGGTCTTTCTTG
ing to the 59 flanking region and the 39UTR obtained from a mouse CAG-39, reverse: 59-CCCCGTGTAGGAATATTACATAAC-39), produc-
PLP cDNA (Nave et al., 1987). A targeting vector for positive– ing a 169 bp fragment. The shiverer allele was identified as a 380
negative selection (Mansour et al., 1988) was constructed by first bp fragment with primers complementary to sequences on either
subcloning a KpnI-BamHI fragment (‘long arm’) comprising most side of the break point located in intron 2 (forward: 59-CAGGGGATG
of introns 1–3 into vector pSP72 (Promega). Next, the neomycin GGGAGTCAGAAGTGAG-39, reverse: 59-ATGTATGTGTGTGTGTGC
resistance gene (from pMCneopA, Stratagene) was cloned 59 to the TTATCTAGTGTA-39).
long arm in antisense orientation. For negative selection, the HSV-
TK gene (from pMC1TK, Stratagene) was inserted XhoI-BamHI at
Motor Performance Assaythe 39 end of the construct. Finally, a 1.5 kb BamHI fragment (‘short
The ‘rotarod-test’ utilized a motor-driven metal roller (2 cm diam-arm’) comprising the PLP promoter and upstream part of the 59UTR
eter 3 10 cm wide) flanked by two larger plates. Male hemizygouswas inserted. In the resulting targeting construct, critical parts of
mutant mice (n 5 6) and the same number of age-matched controlsthe 59UTR between the BamHI site of exon 1 and the most 59 KpnI
were analyzed at 6 months of age and again at 12 months. Assite of intron 1 were deleted, including the translation start site.
additional controls, we used 6-month-old rumpshaker mice (n 5 6)
partly rescued with one copy of the autosomal PLP gene of line #66
Selection of ES Cells
(Readhead et al., 1994; A. Schneider et al., unpublished data). All
R1 mouse ES cells were kindly provided by A. Nagy (Toronto) and
mice were placed on the roller at rest. After 15 s, the rotarod was
cultured on mitomycin-treated primary mouse embryonic fibro-
started at 1 round per min (rpm). In 60 s intervals, the rotating speed
blasts. For electroporation (BioRad Gene Pulser; 240 V; 500 or 960
was successively inceased to 2, 4, 8, 12, 16, and 20 rpm. In a series
mF), 107 ES cells were suspended in 0.8 ml phosphate-buffered
of five trials per animal, the time (in seconds) that the mice remained
saline (PBS), containing 50 mg of the linearized (XhoI) targeting con-
on the roller was scored.
struct. Transfected cells were cultured on gelatinized dishes (Fal-
con), and double selection with 300 mg/ml G418 (Gibco) and 2 mM
RNA Analysisgancyclovir was performed after 48 and 72 hr, respectively; 8–10
Total RNA was isolated from brains of 4-month- and 6-month-olddays after electroporation, double-resistant colonies were picked
mice (RNeasy, Quiagen). For Northern analysis, RNA was size frac-and trypsinized. About one third of each colony was plated onto
tionated on a 1% denaturingagarose gel (10 mg/lane) before blottingfeeder cells. The remaining two thirds of eight clones each were
onto nylon membranes (Nytran). Radiolabeled probes were gener-pooled and washed in PBS, suspended in 50 ml water, heat-lysed
ated by random prime labeling of a mouse PLP cDNA (Nave et al.,at 958C (for 10 min), and digested with 10 mg proteinase K (for 30
1987). Hybridization was performed at 428C in the presence of 50%min at 558C).
formamide, 53 Denhardts, 33SSC, 120 mM phosphate, 1% SDS,To identify homologous recombinants, aliquots of the pooled ly-
200 ng/ml salmon sperm DNA, and 106 cpm/ml radiolabeled probe.sates were used to PCR amplify a 1.7 kb genomic fragment in a 50
Blots were washed to a stringency of 0.23SSC at 558C and autora-ml reaction. The forward primer (sB4ext) corresponded to a PLP
diographically exposed to Kodak X-AR5 film with intensifyinggenomic sequence localized immediately upstream of the 59 homol-
screens (24–48 hr).ogy region (59-AGTCTGTGTCTGGAGAGCAG-39). A reverse primer
(MKneo1) was derived from the neo gene (59-TACGGTATCGCCGCT
CCCGATTCGCA-39). Denaturation was at 948C (for 60 s), annealing Protein Analysis
at 568C (for 45 s), and extension at 728C (for 60 s). Amplification Total brain extracts were made from 200 mg fresh tissue in 7 ml
products were verified by Southern analysis, using a 1.5 kb BamHI PBS, 1% SDS, using a polytron homogenizer at the highest setting
fragment as a 32P-labeled 59-probe. Individual PCR-positive clones (10 s). The homogenate was immediately boiled for 3 min,and insolu-
were confirmed by Southern analysis. Size-separated DNA (10 mg) ble material was pelleted by centrifugation. Myelin was isolated
was blotted and hybridized either to the 59 probe or to a 1.1 kb from homogenized brains in 0.32 M sucrose (Norton, 1974). Equal
XhoI/BamHI fragment of pMCneo. Microinjection of selected ES amounts of protein (10 mg) were size separated on denaturing 12%
cells into C57BL/6J blastocysts was performed by standard proce- SDS–polyacrylamide gels and transferred to supported nitrocellu-
dures. Highly chimeric males were crossed to C57BL/6J females. lose membranes (BA-S 85, Schleicher and Schu¨ll) by semidry elec-
Heterozygous mutants were crossed with C57BL/6J males to obtain troblotting. Membranes were blocked with 5% nonfat dry milk (in
hemizygous mutants. PBS, 0.1% Tween-20) for 1 hr at room temperature. Incubation with
For routine analysis, offspring were genotyped by PCR. Absence antibodies (in PBS containing 2% nonfat dry milk) was for 1 hr,
of the wild-type allele was shown with sB4ext as a forward primer followed by a wash and 1 hr incubation with a horseradish peroxi-
and PLP59a as the reverse primer (59-CTGTTTTGCGGCTGACT dase-conjugated secondary antibody (Amersham), diluted 1:1000
TTG-39), the latter corresponding to the upstream part of exon 1 in the same buffer. Immunoreactive protein was detected with an
that is absent from the mutant allele. The targeted allele was posi- enhanced chemiluminescence kit (ECL, Amersham) according to
tively identified with primers neo4 (59-GGCTATTCGGCTATGACTG the manufacturer’s instructions, using ECL-Hyperfilm (Amersham).
GGC-39) and neo5 (59-GGGTAGCCAACGCTATGTCCTG-39), yielding Western blots were stripped and reprobed with different antibodies.
a 620 bp product specific for the inserted neo gene. The M6A antipeptide antibody M6–7 has been described (Lagenaur
et al., 1992) and was diluted 1:10. Antibodies against MBP (Boeh-
ringer) werediluted 1:500; anti-GFAP, 1:250 (Serva); anti-PO, 1:1000;Transgenic Complementation
Transgenic complementation of the plpnull allele was achieved by anti-OSP, 1:100; anti-M6B, 1:10 (kindly provided by H. Werner); and
PLP/DM20, 1:50, respectively. The PLP antibody (A431) is directedbreeding heterozygous carriers with male mice (lines #66 and 72),
transmitting an autosomal wild-type PLP transgene (Readhead et against the PLP C-terminus (Jung et al., 1996). For total protein
analysis, 5 mg of protein was separated on a 12% SDS–al., 1994). Presence of the transgene was revealed by amplification
of a 250 bp genomic fragment obtained with the forward primer polyacrylamide gel and visualized by silver staining and with Coo-
massie Brilliant Blue.COS39 (59-CAGGTGTTGAGTCTGATCTACACAAG-39) at the 39 end
PLP/DM20 null Mutation
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Histology Fannon, A.M., Mastronardi, F.G., and Moscarello M.A. (1994). Isola-
tion and identification of proteolipid proteins in jimpy mouse brains.Mice were perfused through the left ventricle with saline followed
by a modified Karnovsky fixative with 5% glutaraldehyde–4% para- Neurochem. Res. 19, 1005–1012.
formaldehyde in cacodylate buffer (pH 7.2) (Griffiths et al., 1981). Filbin, M.T., Walsh, F.S., Trapp, B.D., Pizzey, J.A., and Tennekoon,
Tissues were removed and maintained in the same fixative before G.I. (1990). Role of myelin P0 protein as a homophilic adhesion
routine processing for embedding in Araldite. Sections (1 mm) were molecule. Nature 344, 871–872.
stained with methylene blue–azure II, or grids (60 nm) were stained
Giese, K.P., Martini, R., Lemke, G., Soriano, P., and Schachner, M.with uranyl acetate and lead citrate. Other mice were perfused with
(1992). Disruption of the P0 gene in mice leads to abnormal expres-buffered neutral formalin, and tissues were embedded in paraffin.
sion of recognition molecules, and degeneration of myelin and ax-Immunostaining was performed on 1 mm resin sections or 8 mm
ons. Cell 71, 565–576.paraffin sections using the PAP technique. In situ hybridizations on
Gomez, C.N., Muggleton-Harris, A.L., Whittingham, D.G., Hood, L.E.,6 mm paraffin sections were performed by standard procedures
and Readhead, C. (1990). Rapid preimplantation detection of mutantusing 35S-labeled riboprobes spanning the PLP coding region and
(shiverer) and normal alleles of the mouse myelin basic protein gene59 untranslated region (Milner et al., 1985).
allowing selective implantation and birth of live young. Proc. Natl.
Acad. Sci. USA 87, 4481–4484.Acknowledgments
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